Dajun Yang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Chronic Lymphocytic Leukemia

Oxide Nanoparticles

Radiation Therapy

Acinetobacter Baumannii

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Hengbang Wang, Yun Yang, Zi Chen, Lei Tommy Fu, Min Yu, Lixin Jiang, Cunlin Wang, Lichuang Men, Ilisse Minto, Dajun Yang, Yifan Zhai
Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers. Clinical and translational science 17 (9) (2024)
Hengbang Wang, Yun Yang, Zi Chen, Lei Tommy Fu, Min Yu, Lixin Jiang, Cunlin Wang, Lichuang Men, Ilisse Minto, Dajun Yang, Yifan Zhai
Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers. Clinical and translational science 17 (9) (2024)
Nehal J Lakhani, Drew W Rasco, Hengbang Wang, Lichuang Men, Eric Liang, Lei Tommy Fu, Mary C Collins, Ping Min, Yan Yin, Matthew S Davids, Dajun Yang, Yifan Zhai
First-in-Human Study with preclinical data of BCL-2/BCL-xL Inhibitor Pelcitoclax in Locally Advanced or Metastatic Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sikandar Ailawadhi, Zi Chen, Bo Huang, Aneel Paulus, Mary C Collins, Lei Tommy Fu, Mingyu Li, Mohammad Ahmad, Lichuang Men, Hengbang Wang, Matthew S Davids, Eric Liang, Divya J Mekala, Zhicong He, Masa Lasica, Costas K Yannakou, Ricardo D Parrondo, Laura Glass, Dajun Yang, Asher A Chanan-Khan, Yifan Zhai
Novel BCL-2 Inhibitor Lisaftoclax in Relapsed or Refractory Chronic Lymphocytic Leukemia and Other Hematologic Malignancies: First-in-Human Open-Label Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yifan Zhai, Qiuqiong Tang, Douglas D Fang, Jing Deng, Kaixiang Zhang, Qixin Wang, Yan Yin, Chengcheng Fu, Sheng-Li Xue, Na Li, Feng Zhou, Dajun Yang
Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Jing Deng, Aneel Paulus, Douglas D Fang, Alak Manna, Guangfeng Wang, Hengbang Wang, Saijie Zhu, Jianyong Chen, Ping Min, Yan Yin, Navnita Dutta, Nabanita Halder, Gina Ciccio, John A Copland Iii, James L Miller, Bing Han, Longchuan Bai, Liu Liu, Mi Wang, Donna McEachern, Sally Przybranowski, Chao-Yie Yang, Jeanne A Stuckey, De-Pei Wu, Caixia Li, Jeremy Adam Ryan, Anthony G Letai, Sikandar Ailawadhi, Dajun Yang, Shaomeng Wang, Asher A Chanan-Khan, Yifan Zhai
Lisaftoclax (APG-2575) is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)